Global Pricing Strategies for Pharmaceutical Product Launches
نویسنده
چکیده
منابع مشابه
Assessing the Impact of Global Price Interdependencies in a Global Pricing Strategy
Designing a global pricing strategy for a new pharmaceutical product has become increasingly difficult as geographic reference pricing and parallel trade have introduced global price interdependencies between different nations. What may have been an optimal pricing strategy in a single country may no longer be optimal when considering the international ramifications of this price. The prices se...
متن کاملTransfer Pricing and Offshoring in Global Supply Chains
Taking advantage of lower foreign tax rates using transfer pricing and taking advantage of lower production costs using offshoring are two strategies that global companies use to increase their profitability. Evidence suggests that firms employ these strategies independently. We study how global firms can jointly leverage tax and cost differences through coordinated transfer pricing and offshor...
متن کاملEntry Pricing and Product Quality: The Case of Antidepressant Drugs
The rising prices of pharmaceuticals have generated considerable, and often acrimonious, debate. Yet, there is little theoretical work or empirical evidence on pharmaceutical entry-pricing strategies or on the time paths of the prices of new entrants versus incumbents. This study explores the entry pricing strategies of pharmaceutical manufacturers. Previous theoretical models have considered a...
متن کاملAffordable innovation: future directions in pharmaceutical policy
In 2009, Jayadev and Stiglitz [1] proposed ‘two ideas’ to increase innovation and reduce pharmaceutical costs and prices. These were the use of value-based pricing and promoting public funding of clinical trials. Since then, NICE has tried and not yet succeeded to introduce value-based pricing, Persson and Jonsson [2] suggest that international reference pricing should cease, Gilead has made bi...
متن کاملSleeping with the Enemy: Inter-firm Product Combinations in the Pharmaceutical Indsutry
There is a substantial literature in economics that focuses on explaining the reasons for intra-firm product combinations, such as bundling. Little is known, however, about the implications of inter-firm product combinations that are frequent in pharmaceutical markets. We propose and estimate a model to study the pricing strategies and the welfare effects of this practice. We find that firms in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2003